Table 1 Baseline demographics and clinical characteristics of healthy controls and patients with medication-related osteonecrosis of the jaw (MRONJ).
Characteristics | Control (N = 15) | MRONJ (N = 16) | P-value | ||
|---|---|---|---|---|---|
Age (y) | Mean ± SD | 62.2 ± 7.4 | 74.2 ± 9.0 | < 0.001 | |
Sex | N (%) | 1.000 | |||
M | 0 (0.0) | 0 (0.0) | |||
F | 15 (100.0) | 16 (100.0) | |||
Diabetes mellitus | N (%) | 0.172 | |||
Yes | 1 (6.7) | 5 (31.2) | |||
No | 14 (93.3) | 11 (68.8) | |||
Chronic steroid exposure | N (%) | 1.000 | |||
Yes | 0 (0.0) | 0 (0.0) | |||
No | 15 (100.0) | 16 (100.0) | |||
Alcohol consumption | N (%) | < 0.001 | |||
Yes | 10 (66.7) | 0 (0.0) | |||
No | 5 (33.3) | 16 (100.0) | |||
Smoking | N (%) | 1.000 | |||
Yes | 0 (0.0) | 0 (0.0) | |||
No | 15 (100.0) | 16 (100.0) | |||
Cardiovascular diseases | N (%) | 1.000 | |||
Yes | 1 (6.7) | 1 (6.2) | |||
No | 14 (93.3) | 15 (93.8) | |||
